COVID - 19 Impact on Pharma Industry

White Paper

Will The Pharma Industry’s Response To COVID-19 Positively Affect Its Image? A Commentary

The pharmaceutical industry has stepped up in a big way in search of vaccines and effective treatments for COVID-19. One reference cited at least 250 drugs and 95 vaccines under in ...

Effects of a resurgence in COVID-19 cases on future pharma business planning

White Paper

Effects Of A Resurgence In COVID-19 Cases On Future Pharmaceutical Business Planning

Fears have arisen regarding a resurgence in COVID-19 cases. Numerous factors could be contributing to a resurgence in COVID-19 cases. Some suggest it is because more tests are bein ...

COVID-19 Recession Effects on Pharmaceutical Patient Health Outcomes

White Paper

COVID-19 Recession Effects On Pharmaceutical-Related Patient Health Outcomes

This white paper investigates the research framework to model the expected effects on the decline in health outcomes caused by a decrease in the quantity and quality of pharmaceuti ...

Coronavirus Pandemic Effects On Incentive Compensation

White Paper

Coronavirus Pandemic Effects On Incentive Compensation

This paper focuses on coronavirus pandemic effects on IC for pharma companies in the short-term, medium-term, and long-term, while also providing prescriptive actions for sales exe ...